Drug profile · INN
olsalazine sodium
DIPENTUM
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
olsalazine sodium (DIPENTUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN olsalazine sodium
Brand DIPENTUM
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is olsalazine sodium?
olsalazine sodium (DIPENTUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for olsalazine sodium?
DIPENTUM is a marketed brand name for olsalazine sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of olsalazine sodium?
olsalazine sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.